Nkarta (NKTX) Accumulated Depreciation (2019 - 2026)
Nkarta (NKTX) posted quarterly Accumulated Depreciation of $31.3 million for Q1 2026, up 35.2% year-over-year from $23.1 million in Q1 2025, and up 8.08% quarter-over-quarter from $29.0 million in Q4 2025.
Nkarta (NKTX) Accumulated Depreciation (2019 - 2026) Analysis & Trends
Nkarta's Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $31.3 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 35.2% year-over-year to $31.3 million; the TTM figure through Mar 2026 stood at $31.3 million (up 35.2% YoY), while the FY2025 annual figure was $29.0 million, up 38.89% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $31.3 million, up from $29.0 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $31.3 million in Q1 2026, with the low at $3.8 million in Q1 2022.
- The 5-year median for Accumulated Depreciation is $13.9 million (2024), against an average of $15.3 million.
- The sharpest annual moves came in 2022 and 2026: Accumulated Depreciation jumped 119.23% in 2022, then surged 35.2% in 2026.
- Nkarta's Accumulated Depreciation stood at $5.8 million in 2022, then surged by 100.77% to $11.7 million in 2023, then surged by 78.27% to $20.8 million in 2024, then surged by 38.89% to $29.0 million in 2025, then gained by 8.08% to $31.3 million in 2026.
- Business Quant data shows NKTX's Accumulated Depreciation at $31.3 million in Q1 2026, $29.0 million in Q4 2025, and $27.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.13 Mn |
| Mar 31, 2026 | 31.29 Mn |
| Dec 31, 2025 | 28.95 Mn |
| Sep 30, 2025 | 27.78 Mn |
| Jun 30, 2025 | 25.48 Mn |
| Mar 31, 2025 | 23.14 Mn |
| Dec 31, 2024 | 20.85 Mn |
| Sep 30, 2024 | 18.56 Mn |
| Jun 30, 2024 | 16.21 Mn |
| Mar 31, 2024 | 13.95 Mn |
| Dec 31, 2023 | 11.69 Mn |
| Sep 30, 2023 | 9.44 Mn |
| Jun 30, 2023 | 7.46 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 5.82 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 4.43 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 3.19 Mn |
| Sep 30, 2021 | 2.63 Mn |